2022
DOI: 10.1007/s13205-022-03272-6
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2

Abstract: We used human semi-synthetic phage antibody gene libraries to select anti-SARS-CoV-2 RBD scFv antibody fragment and subsequent characterization of this novel tetravalent monoclonal antibody targeting conformational epitopes in the receptor binding domain of SARS-CoV-2. Binding studies suggest that II62 tetravalent antibody cross-reacts with RBD protein of SARS-CoV2 and its different variants of concerns. The epitope mapping data reveals that II62 tetravalent antibody targets an epitope that does not directly i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…When selecting nanoparticles, it is important to pay attention to the drugs required to resist the novel coronavirus infection and its concurrent mixed viral infections. For this reason, the list of studied nanoparticles includes monoclonal antibodies to SARS-CoV-2 [ 8 ], VLPs to SARS-CoV-2 and the rotavirus [ 9 , 10 , 11 ], humic–fulvic acids [ 12 ], and preparations of interferons and antibodies to these viruses. [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…When selecting nanoparticles, it is important to pay attention to the drugs required to resist the novel coronavirus infection and its concurrent mixed viral infections. For this reason, the list of studied nanoparticles includes monoclonal antibodies to SARS-CoV-2 [ 8 ], VLPs to SARS-CoV-2 and the rotavirus [ 9 , 10 , 11 ], humic–fulvic acids [ 12 ], and preparations of interferons and antibodies to these viruses. [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%